Verici Dx Announces the Abstracts Accepted for the 2025 World Transplant Congress
Verici Dx Plc (LSE:VRCI) FRANKLIN, TN, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, is proud to announce the abstracts highlighting real-world clinical use of …